S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
66,000% upside on tiny biotech? (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AI Stock Caught Trading Under Secret Name (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
AI Stock Caught Trading Under Secret Name (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
66,000% upside on tiny biotech? (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AI Stock Caught Trading Under Secret Name (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
AI Stock Caught Trading Under Secret Name (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
66,000% upside on tiny biotech? (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AI Stock Caught Trading Under Secret Name (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
AI Stock Caught Trading Under Secret Name (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
66,000% upside on tiny biotech? (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AI Stock Caught Trading Under Secret Name (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
What recession? Professional forecasters raise expectations for US economy in 2024
AI Stock Caught Trading Under Secret Name (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

$7.78
-0.69 (-8.15%)
(As of 02/23/2024 08:53 PM ET)
Today's Range
$7.26
$8.17
50-Day Range
$7.78
$11.21
52-Week Range
$6.60
$15.87
Volume
1.75 million shs
Average Volume
578,549 shs
Market Capitalization
$447.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.38

Health Catalyst MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
72.0% Upside
$13.38 Price Target
Short Interest
Healthy
2.61% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
0.30mentions of Health Catalyst in the last 14 days
Based on 26 Articles This Week
Insider Trading
Selling Shares
$50,692 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.84) to ($0.76) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.79 out of 5 stars

Medical Sector

46th out of 936 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

3rd out of 56 stocks


HCAT stock logo

About Health Catalyst Stock (NASDAQ:HCAT)

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company offers data operating system data platform for analytics, and application development and interoperability that provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications designed to analyze the problems faced across clinical and quality, population health, and financial and operational use cases. It also provides services expertise, which include data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.

HCAT Stock Price History

HCAT Stock News Headlines

New Trump Bombshell
I believe Donald J. Trump will go down as America’s last Republican president.  But NOT for the reasons you may think…  If I’m right, the soul of this country will change forever…
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
Analyst Scoreboard: 5 Ratings For Health Catalyst
Q4 2023 Health Catalyst Inc Earnings Call
Health Catalyst Inc (HCAT)
See More Headlines
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2021
Today
2/25/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Current Symbol
NASDAQ:HCAT
Fax
N/A
Employees
1,200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.38
High Stock Price Target
$18.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+72.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
13 Analysts

Profitability

Net Income
$-137,400,000.00
Pretax Margin
-42.53%

Debt

Sales & Book Value

Annual Sales
$295.94 million
Book Value
$7.76 per share

Miscellaneous

Free Float
55,996,000
Market Cap
$447.74 million
Optionable
Optionable
Beta
1.35
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report














HCAT Stock Analysis - Frequently Asked Questions

Should I buy or sell Health Catalyst stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HCAT shares.
View HCAT analyst ratings
or view top-rated stocks.

What is Health Catalyst's stock price target for 2024?

13 Wall Street research analysts have issued 1 year target prices for Health Catalyst's stock. Their HCAT share price targets range from $8.00 to $18.00. On average, they anticipate the company's share price to reach $13.38 in the next twelve months. This suggests a possible upside of 72.0% from the stock's current price.
View analysts price targets for HCAT
or view top-rated stocks among Wall Street analysts.

How have HCAT shares performed in 2024?

Health Catalyst's stock was trading at $9.26 at the beginning of the year. Since then, HCAT shares have decreased by 16.0% and is now trading at $7.78.
View the best growth stocks for 2024 here
.

Are investors shorting Health Catalyst?

Health Catalyst saw a decline in short interest during the month of January. As of January 31st, there was short interest totaling 1,500,000 shares, a decline of 15.7% from the January 15th total of 1,780,000 shares. Based on an average trading volume of 547,500 shares, the short-interest ratio is currently 2.7 days.
View Health Catalyst's Short Interest
.

When is Health Catalyst's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our HCAT earnings forecast
.

How were Health Catalyst's earnings last quarter?

Health Catalyst, Inc. (NASDAQ:HCAT) announced its quarterly earnings results on Tuesday, November, 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.04. The business earned $61.74 million during the quarter, compared to analysts' expectations of $60.95 million. Health Catalyst had a negative net margin of 39.92% and a negative trailing twelve-month return on equity of 11.99%. During the same period last year, the company earned ($0.44) earnings per share.

What guidance has Health Catalyst issued on next quarter's earnings?

Health Catalyst issued an update on its first quarter 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $72.5 million-$76.5 million, compared to the consensus revenue estimate of $79.0 million.

What is Dan Burton's approval rating as Health Catalyst's CEO?

501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL).

When did Health Catalyst IPO?

(HCAT) raised $129 million in an initial public offering (IPO) on Thursday, July 25th 2019. The company issued 6,000,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Who are Health Catalyst's major shareholders?

Health Catalyst's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.57%), Point72 Asset Management L.P. (7.22%), Impax Asset Management Group plc (3.05%), Dimensional Fund Advisors LP (2.69%), Primecap Management Co. CA (2.47%) and Granahan Investment Management LLC (2.14%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn and Paul Horstmeier.
View institutional ownership trends
.

How do I buy shares of Health Catalyst?

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HCAT) was last updated on 2/26/2024 by MarketBeat.com Staff